CN108318465B - A kind of detection method of heme solution concentration - Google Patents
A kind of detection method of heme solution concentration Download PDFInfo
- Publication number
- CN108318465B CN108318465B CN201810129543.1A CN201810129543A CN108318465B CN 108318465 B CN108318465 B CN 108318465B CN 201810129543 A CN201810129543 A CN 201810129543A CN 108318465 B CN108318465 B CN 108318465B
- Authority
- CN
- China
- Prior art keywords
- solution
- heme
- concentration
- thiamine
- artemisinin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000003278 haem Chemical class 0.000 title claims abstract description 92
- 238000001514 detection method Methods 0.000 title claims abstract description 23
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims abstract description 36
- 239000011721 thiamine Substances 0.000 claims abstract description 36
- 229960003495 thiamine Drugs 0.000 claims abstract description 36
- 235000019157 thiamine Nutrition 0.000 claims abstract description 36
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims abstract description 34
- 239000000243 solution Substances 0.000 claims description 79
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 claims description 35
- 229960004191 artemisinin Drugs 0.000 claims description 35
- 229930101531 artemisinin Natural products 0.000 claims description 35
- 238000011534 incubation Methods 0.000 claims description 29
- 239000012086 standard solution Substances 0.000 claims description 26
- 150000007529 inorganic bases Chemical class 0.000 claims description 18
- 239000011259 mixed solution Substances 0.000 claims description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 11
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 11
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 abstract description 14
- 238000002038 chemiluminescence detection Methods 0.000 abstract description 4
- 238000001506 fluorescence spectroscopy Methods 0.000 abstract description 4
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 abstract description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract description 3
- 239000000049 pigment Substances 0.000 abstract description 3
- 229910052717 sulfur Inorganic materials 0.000 abstract description 3
- 239000011593 sulfur Substances 0.000 abstract description 3
- 239000003513 alkali Substances 0.000 description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- -1 iron porphyrin compound Chemical class 0.000 description 3
- 229910021645 metal ion Inorganic materials 0.000 description 3
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 2
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229910001429 cobalt ion Inorganic materials 0.000 description 2
- XLJKHNWPARRRJB-UHFFFAOYSA-N cobalt(2+) Chemical compound [Co+2] XLJKHNWPARRRJB-UHFFFAOYSA-N 0.000 description 2
- 229910001431 copper ion Inorganic materials 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 238000002189 fluorescence spectrum Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229910001425 magnesium ion Inorganic materials 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000003544 thiamines Chemical class 0.000 description 2
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 208000016988 Hemorrhagic Stroke Diseases 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000006931 brain damage Effects 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 208000020658 intracerebral hemorrhage Diseases 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N21/643—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" non-biological material
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Optics & Photonics (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
本发明提供一种血红素溶液浓度的检测方法,属于生物检测领域。本发明使用硫胺素代替鲁米诺,成本低且较为环保,荧光信号较为稳定,提高了检测结果的重现性,青蒿素在血红素存在时,分解产生超氧自由基,硫胺素本身没有荧光,在超氧自由基存在时,氧化生成有荧光性质的硫色素,利用荧光光谱法检测血红素浓度,相比化学发光法检测,重现性较好。实施例的数据表明,本发明提供的检测方法对300nmol/L的血红素进行了6次重复测定,相对标准偏差为6.8%。
The invention provides a method for detecting the concentration of heme solution, which belongs to the field of biological detection. The invention uses thiamine instead of luminol, has low cost and is relatively environmentally friendly, the fluorescent signal is relatively stable, and the reproducibility of the detection result is improved. It has no fluorescence itself. In the presence of superoxide radicals, it oxidizes to generate sulfur pigments with fluorescent properties. The heme concentration is detected by fluorescence spectroscopy, which has better reproducibility than chemiluminescence detection. The data of the examples show that the detection method provided by the present invention has carried out 6 repeated determinations of 300 nmol/L heme, and the relative standard deviation is 6.8%.
Description
技术领域technical field
本发明涉及生物检测技术领域,特别涉及一种血红素溶液浓度的检测方法。The invention relates to the technical field of biological detection, in particular to a method for detecting the concentration of heme solution.
背景技术Background technique
血红素是一种天然的卟啉铁合物,在氧运输中起着关键的作用,它使人体器官正常运转。过量的血红素可能导致出血性中风后永久性的脑继发性损害,而血红素的缺乏可能会诱导神经细胞中的神经球蛋白表达,加速内源性一氧化碳的产生。此外,其作为一种新型的铁补充剂,被广泛应用于药物,食品及其他领域中。Heme, a natural iron porphyrin compound, plays a key role in oxygen transport, which enables the normal functioning of human organs. Excessive heme may lead to permanent secondary brain damage after hemorrhagic stroke, while heme deficiency may induce neuroglobulin expression in nerve cells, accelerating endogenous carbon monoxide production. In addition, as a new type of iron supplement, it is widely used in medicine, food and other fields.
目前,报道检测血红素的方法有化学发光法,电化学法,毛细管电泳法及荧光光光谱法等,存在检测方法重现性差的问题,如徐等人利用青蒿素-鲁米诺体系实现了血红素的化学发光法检测,不同浓度的血红素加入到含有鲁米诺及青蒿素的缓冲溶液中,进行化学发光检测(参见《Artemisinin-luminol chemiluminescence for forensic bloodstaindetection using a smart phone as a detector》,G.B.Xu等,Anal.Chem.,2017,89:6160~6165),但是鲁米诺发光时间有限,样品制备好后需要立刻进行测量,重现性差。At present, the reported methods for the detection of heme include chemiluminescence, electrochemical, capillary electrophoresis and fluorescence spectroscopy, etc., but there is a problem of poor reproducibility of the detection methods. For example, Xu et al. used the artemisinin-luminol system to achieve The chemiluminescence detection of heme was carried out by adding different concentrations of heme into the buffer solution containing luminol and artemisinin for chemiluminescence detection (see "Artemisinin-luminol chemiluminescence for forensic bloodstain detection using a smart phone as a detector"). ", G.B.Xu et al., Anal.Chem., 2017, 89: 6160-6165), but the luminol luminescence time is limited, the sample needs to be measured immediately after preparation, and the reproducibility is poor.
发明内容SUMMARY OF THE INVENTION
本发明的目的在于提供一种血红素溶液浓度的检测方法,重现性好。The purpose of the present invention is to provide a method for detecting the concentration of heme solution with good reproducibility.
本发明提供了一种血红素溶液浓度的检测方法,包括以下步骤:The invention provides a method for detecting the concentration of heme solution, comprising the following steps:
(1)将待测血红素溶液、乙二胺四乙酸二钠、青蒿素、硫胺素、无机碱与水混合,将得到的待测混合溶液进行孵育,得到待测孵育溶液,检测所述待测孵育溶液的荧光强度;(1) Mix the heme solution to be tested, disodium EDTA, artemisinin, thiamine, and inorganic base with water, incubate the obtained mixed solution to be tested to obtain the incubation solution to be tested, and detect the the fluorescence intensity of the incubation solution to be tested;
(2)根据所述步骤(1)得到的待测孵育溶液的荧光强度以及预定的标准曲线,得到待测血红素溶液中血红素的浓度;所述标准曲线以血红素标准溶液的浓度为横坐标、以加入血红素标准溶液后的荧光强度与青蒿素和硫胺素混合溶液的初始荧光强度的差值为纵坐标。(2) Obtain the concentration of heme in the heme solution to be measured according to the fluorescence intensity of the incubation solution to be measured and the predetermined standard curve obtained in the step (1); the standard curve takes the concentration of the standard heme solution as the horizontal Coordinate, the difference between the fluorescence intensity after adding the heme standard solution and the initial fluorescence intensity of the mixed solution of artemisinin and thiamine is the ordinate.
优选地,所述步骤(1)中孵育的温度为15~40℃,所述孵育的时间为 5~30min。Preferably, the incubation temperature in the step (1) is 15-40°C, and the incubation time is 5-30 min.
优选地,所述步骤(1)中待测血红素溶液中青蒿素与硫胺素的摩尔比为 10~2000:0.5~500。Preferably, in the step (1), the molar ratio of artemisinin and thiamine in the heme solution to be tested is 10-2000:0.5-500.
优选地,所述步骤(1)中无机碱为氢氧化钠或氢氧化钾。Preferably, in the step (1), the inorganic base is sodium hydroxide or potassium hydroxide.
优选地,所述步骤(1)中无机碱以无机碱溶液的形式加入,所述无机碱溶液的浓度为5~500mmol/L。Preferably, in the step (1), the inorganic alkali is added in the form of an inorganic alkali solution, and the concentration of the inorganic alkali solution is 5-500 mmol/L.
优选地,所述步骤(1)中青蒿素以青蒿素溶液的形式加入,所述青蒿素溶液的浓度为0.05~50mmol/L。Preferably, in the step (1), artemisinin is added in the form of an artemisinin solution, and the concentration of the artemisinin solution is 0.05-50 mmol/L.
优选地,所述步骤(1)中硫胺素以硫胺素溶液的形式加入,所述硫胺素溶液的浓度为5μmol/L~2mmol/L。Preferably, in the step (1), thiamine is added in the form of a thiamine solution, and the concentration of the thiamine solution is 5 μmol/L˜2 mmol/L.
优选地,所述步骤(2)中标准曲线的线性范围为2.0~300.0nmol/L。Preferably, the linear range of the standard curve in the step (2) is 2.0-300.0 nmol/L.
本发明提供了一种血红素溶液浓度的检测方法,包括以下步骤:将待测血红素溶液、乙二胺四乙酸二钠、青蒿素、硫胺素、无机碱与水混合,将得到的待测混合溶液进行孵育,得到待测孵育溶液,检测所述待测孵育溶液的荧光强度;根据待测孵育溶液的荧光强度以及预定的标准曲线,得到待测血红素溶液中血红素的浓度;所述标准曲线以血红素标准溶液的浓度为横坐标、以加入血红素标准溶液后的荧光强度与青蒿素和硫胺素混合溶液的初始荧光强度的差值为纵坐标。本发明使用硫胺素代替鲁米诺,成本低且较为环保,荧光信号较为稳定,提高了检测结果的重现性,青蒿素在血红素存在时,分解产生超氧自由基,硫胺素本身没有荧光,在超氧自由基存在时,氧化生成有荧光性质的硫色素,利用荧光光谱法检测血红素浓度,相比化学发光法检测,重现性较好。实施例的数据表明,本发明提供的检测方法对300nmol/L 的血红素溶液进行了6次重复测定,相对标准偏差为6.8%。且具有良好的选择性。The invention provides a method for detecting the concentration of heme solution, comprising the following steps: mixing the heme solution to be measured, disodium EDTA, artemisinin, thiamine, inorganic base and water, The mixed solution to be tested is incubated to obtain the incubation solution to be tested, and the fluorescence intensity of the incubation solution to be tested is detected; according to the fluorescence intensity of the incubation solution to be tested and a predetermined standard curve, the concentration of heme in the heme solution to be tested is obtained; The standard curve takes the concentration of the heme standard solution as the abscissa, and the difference between the fluorescence intensity after adding the heme standard solution and the initial fluorescence intensity of the mixed solution of artemisinin and thiamine as the ordinate. The invention uses thiamine instead of luminol, has low cost and is relatively environmentally friendly, the fluorescent signal is relatively stable, and the reproducibility of the detection result is improved. It has no fluorescence itself. In the presence of superoxide radicals, it oxidizes to generate sulfur pigments with fluorescent properties. The heme concentration is detected by fluorescence spectroscopy, which has better reproducibility than chemiluminescence detection. The data of the examples show that the detection method provided by the present invention has carried out 6 repeated determinations on the heme solution of 300 nmol/L, and the relative standard deviation is 6.8%. and has good selectivity.
附图说明Description of drawings
图1是本发明实施例1加入不同浓度血红素标准溶液后荧光强度的变化;Fig. 1 is the change of fluorescence intensity after adding different concentrations of heme standard solution in the embodiment of the present invention 1;
图2是本发明实施例1体系荧光强度与血红素浓度关系曲线,插图为荧光强度变化和血红素的标准方程;Fig. 2 is the relation curve of fluorescence intensity and heme concentration of the system in Example 1 of the present invention, and the inset is the standard equation of fluorescence intensity change and heme;
图3是本发明实施例2其他干扰物质加入后体系荧光强度变化。Fig. 3 is the fluorescence intensity change of the system after the addition of other interfering substances in Example 2 of the present invention.
具体实施方式Detailed ways
本发明提供了一种血红素溶液浓度的检测方法,包括以下步骤:The invention provides a method for detecting the concentration of heme solution, comprising the following steps:
(1)将待测血红素溶液、乙二胺四乙酸二钠、青蒿素、硫胺素、无机碱与水混合,将得到的待测混合溶液进行孵育,得到待测孵育溶液,检测所述待测孵育溶液的荧光强度;(1) Mix the heme solution to be tested, disodium EDTA, artemisinin, thiamine, and inorganic base with water, incubate the obtained mixed solution to be tested to obtain the incubation solution to be tested, and detect the the fluorescence intensity of the incubation solution to be tested;
(2)根据所述步骤(1)得到的待测孵育溶液的荧光强度以及预定的标准曲线,得到待测血红素溶液中血红素的浓度;所述标准曲线以血红素标准溶液的浓度为横坐标、以加入血红素标准溶液后的荧光强度与青蒿素和硫胺素混合溶液的初始荧光强度的差值为纵坐标。(2) Obtain the concentration of heme in the heme solution to be measured according to the fluorescence intensity of the incubation solution to be measured and the predetermined standard curve obtained in the step (1); the standard curve takes the concentration of the standard heme solution as the horizontal Coordinate, the difference between the fluorescence intensity after adding the heme standard solution and the initial fluorescence intensity of the mixed solution of artemisinin and thiamine is the ordinate.
本发明将待测血红素溶液、乙二胺四乙酸二钠、青蒿素、硫胺素、无机碱与水混合,得到待测混合溶液进行孵育,得到待测孵育溶液,检测待测孵育溶液的荧光强度。在本发明中,所述孵育的温度优选为15~40℃,更优选为 25℃,所述孵育的时间优选为5~30min,更优选为20min。In the present invention, the heme solution to be tested, disodium EDTA, artemisinin, thiamine and inorganic base are mixed with water to obtain the mixed solution to be tested and incubated to obtain the incubation solution to be tested, and the incubation solution to be tested is detected fluorescence intensity. In the present invention, the incubation temperature is preferably 15-40°C, more preferably 25°C, and the incubation time is preferably 5-30 min, more preferably 20 min.
在本发明中,所述待测血红素溶液中青蒿素与硫胺素的摩尔比优选为 10~2000:0.5~500。In the present invention, the molar ratio of artemisinin to thiamine in the heme solution to be tested is preferably 10-2000:0.5-500.
本发明中,血红素溶液浓度的检测原理为:青蒿素在血红素存在时,分解产生超氧自由基;硫胺素本身没有荧光,在超氧自由基存在时,氧化生成有荧光的硫色素,如下式所示:In the present invention, the detection principle of the concentration of heme solution is as follows: artemisinin is decomposed to generate superoxide radicals in the presence of heme; thiamine itself has no fluorescence, and in the presence of superoxide radicals, it oxidizes to generate fluorescent sulfur Pigment, as shown in the following formula:
。 .
在本发明中,所述待测混合溶液的pH值优选为12~13。本发明通过无机碱的用量调节待测混合溶液的pH值。在本发明中,所述无机碱优选为氢氧化钠或氢氧化钾。在本发明中,所述无机碱优选以无机碱溶液的形式加入,所述无机碱溶液的浓度优选为5~500mmol/L,更优选为5,10,20,50,100, 200,500mmol/L;所述无机碱溶液的体积为870μL。In the present invention, the pH value of the mixed solution to be tested is preferably 12-13. The invention adjusts the pH value of the mixed solution to be tested by the amount of the inorganic base. In the present invention, the inorganic base is preferably sodium hydroxide or potassium hydroxide. In the present invention, the inorganic alkali is preferably added in the form of an inorganic alkali solution, and the concentration of the inorganic alkali solution is preferably 5-500 mmol/L, more preferably 5, 10, 20, 50, 100, 200, 500 mmol/L. L; the volume of the inorganic base solution is 870 μL.
在本发明中,所述待测血红素溶液的浓度优选为2.0~300.0nmol/L。In the present invention, the concentration of the heme solution to be tested is preferably 2.0-300.0 nmol/L.
金属离子、葡萄糖和氨基酸对本发明提供的血红素溶液浓度的检测方法没有影响,不会影响本发明检测方法的选择性。在本发明中,所述金属离子优选包括钴离子、镁离子、铜离子、锌离子和铁离子;所述氨基酸优选包括苯丙氨酸、亮氨酸、甘氨酸、丙氨酸和半胱氨酸。Metal ions, glucose and amino acids have no influence on the method for detecting the concentration of heme solution provided by the present invention, and will not affect the selectivity of the detecting method of the present invention. In the present invention, the metal ions preferably include cobalt ion, magnesium ion, copper ion, zinc ion and iron ion; the amino acid preferably includes phenylalanine, leucine, glycine, alanine and cysteine .
在本发明中,所述青蒿素优选以青蒿素溶液的形式加入,所述青蒿素溶液的优选浓度为0.05~50mmol/L,更优选为5mmol/L;所述青蒿素溶液的加入体积优选为10μL。In the present invention, the artemisinin is preferably added in the form of an artemisinin solution, and the preferred concentration of the artemisinin solution is 0.05-50 mmol/L, more preferably 5 mmol/L; The addition volume is preferably 10 μL.
在本发明中,所述硫胺素优选以硫胺素溶液的形式加入,所述硫胺素溶液的浓度优选为5μmol/L~2mmol/L,更优选为1mmol/L;所述硫胺素溶液的加入体积优选为100μL。In the present invention, the thiamine is preferably added in the form of a thiamine solution, and the concentration of the thiamine solution is preferably 5 μmol/L to 2 mmol/L, more preferably 1 mmol/L; The added volume of the solution is preferably 100 μL.
本发明对所述乙二胺四乙酸二钠(EDTA)的用量没有特殊的限定,对待测混合溶液没有影响即可。The present invention has no special limitation on the amount of disodium ethylenediaminetetraacetate (EDTA), as long as it has no effect on the mixed solution to be tested.
本发明对所述待测血红素溶液、乙二胺四乙酸二钠、青蒿素、硫胺素、无机碱与水的加入顺序没有特殊的限定,采用本领域技术人员熟知的加料顺序即可,具体的,将乙二胺四乙酸二钠、青蒿素溶液、硫胺素溶液、待测血红素溶液依次加入到无机碱溶液中。The present invention has no special limitation on the addition order of the heme solution to be tested, disodium EDTA, artemisinin, thiamine, inorganic base and water, and the order of addition well known to those skilled in the art can be used. Specifically, disodium EDTA, artemisinin solution, thiamine solution, and heme solution to be tested are sequentially added to the inorganic alkali solution.
本发明对所述检测待测孵育溶液的荧光强度的方式没有特殊的限定,采用本领域技术人员熟知的荧光光谱法测定血红素的方式即可。The present invention has no particular limitation on the method of detecting the fluorescence intensity of the incubation solution to be tested, and the method of measuring heme by fluorescence spectroscopy well known to those skilled in the art may be used.
得到待测孵育溶液的荧光强度值后,本发明根据得到的待测孵育溶液的荧光强度以及预定的标准曲线,得到待测血红素溶液中血红素的浓度;所述标准曲线以血红素标准溶液的浓度(c)为横坐标、以加入血红素标准溶液后的荧光强度与青蒿素和硫胺素混合溶液的初始荧光强度的差值为纵坐标。在本发明的实施例中,所述标准曲线为ΔF=32.01+23.54c(c单位是nmol/L),线性系数为0.9954,线性范围是2.0~300.0nmol/L,检出限为0.68nmol/L。在本发明中,所述标准曲线的获取方法优选包括以下步骤:After obtaining the fluorescence intensity value of the incubation solution to be measured, the present invention obtains the concentration of heme in the heme solution to be measured according to the obtained fluorescence intensity of the incubation solution to be measured and a predetermined standard curve; the standard curve is based on the standard heme solution. The concentration (c) of α is the abscissa, and the difference between the fluorescence intensity after adding the heme standard solution and the initial fluorescence intensity of the mixed solution of artemisinin and thiamine is the ordinate. In the embodiment of the present invention, the standard curve is ΔF=32.01+23.54c (the unit of c is nmol/L), the linear coefficient is 0.9954, the linear range is 2.0-300.0 nmol/L, and the detection limit is 0.68 nmol/L L. In the present invention, the method for obtaining the standard curve preferably includes the following steps:
提供血红素标准溶液;Provide heme standard solution;
将乙二胺四乙酸二钠、青蒿素、硫胺素、无机碱与水混合,再加入所述血红素标准溶液,检测加入所述血红素标准溶液后的荧光强度;Mix disodium EDTA, artemisinin, thiamine and inorganic base with water, then add the heme standard solution, and detect the fluorescence intensity after adding the heme standard solution;
以加入血红素标准溶液后的荧光强度与青蒿素和硫胺素混合溶液的初始荧光强度的差值为纵坐标,血红素标准溶液的浓度为横坐标,线性拟合得到标准曲线。Taking the difference between the fluorescence intensity after adding the heme standard solution and the initial fluorescence intensity of the mixed solution of artemisinin and thiamine as the ordinate, and the concentration of the heme standard solution as the abscissa, the standard curve was obtained by linear fitting.
本发明将标准血红素与水混合,得到血红素标准溶液,测定血红素标准溶液的荧光强度。在本发明中,所述血红素标准溶液的浓度优选为0.002、 0.005、0.01、0.05、0.1、0.2、0.3、0.5、0.8、2.0、5.0或10.0μmol/L。本发明对所述标准血红素的来源没有特殊的限定,采用本领域技术人员熟知的血红素标准品即可。In the invention, the standard heme is mixed with water to obtain the heme standard solution, and the fluorescence intensity of the heme standard solution is measured. In the present invention, the concentration of the heme standard solution is preferably 0.002, 0.005, 0.01, 0.05, 0.1, 0.2, 0.3, 0.5, 0.8, 2.0, 5.0 or 10.0 μmol/L. The source of the standard heme is not particularly limited in the present invention, and a standard heme known to those skilled in the art can be used.
得到血红素标准溶液后,本发明将将乙二胺四乙酸二钠、青蒿素、硫胺素、无机碱与水混合,再加入所述血红素标准溶液,检测加入所述血红素标准溶液后的荧光强度;以加入血红素标准溶液后的荧光强度与青蒿素和硫胺素混合溶液的初始荧光强度的差值为纵坐标,血红素标准溶液的浓度为横坐标,线性拟合得到标准曲线。After obtaining the heme standard solution, the present invention will mix disodium EDTA, artemisinin, thiamine, inorganic base with water, then add the heme standard solution, and detect adding the heme standard solution The difference between the fluorescence intensity after adding the heme standard solution and the initial fluorescence intensity of the mixed solution of artemisinin and thiamine is the ordinate, the concentration of the heme standard solution is the abscissa, and the linear fitting is obtained. standard curve line.
在本发明中,所述青蒿素与硫胺素的摩尔比优选为与上述方案中限定的要求一致,在此不再赘述。本发明对所述青蒿素、硫胺素、无机碱以及EDTA、荧光强度的检测方法的限定与上述要求一致,在此不再赘述。In the present invention, the molar ratio of artemisinin and thiamine is preferably consistent with the requirements defined in the above scheme, which will not be repeated here. The limitations of the present invention on the detection methods of artemisinin, thiamine, inorganic base, EDTA, and fluorescence intensity are consistent with the above requirements, and will not be repeated here.
本发明对所述孵育的条件优选为与上述方案所述一致,在此不再赘述。The conditions for the incubation in the present invention are preferably the same as those described in the above scheme, which will not be repeated here.
得到加入血红素标准溶液后的荧光强度(F),以加入血红素标准溶液后的荧光强度(F)与青蒿素和硫胺素混合溶液的初始荧光强度(F0)的差值(ΔF) 为因变量,以血红素标准溶液的浓度(c)为自变量拟合标准方程,根据标准方程计算得到待测血红素溶液中血红素的浓度。Obtain the fluorescence intensity (F) after adding the heme standard solution, as the difference (ΔF) between the fluorescence intensity (F) after adding the heme standard solution and the initial fluorescence intensity (F 0 ) of the mixed solution of artemisinin and thiamine ) is the dependent variable, the standard equation is fitted with the concentration (c) of the heme standard solution as the independent variable, and the concentration of heme in the heme solution to be tested is calculated according to the standard equation.
为了进一步说明本发明,下面结合实施例对本发明提供的血红素溶液浓度的检测方法进行详细地描述,但不能将它们理解为对本发明保护范围的限定。In order to further illustrate the present invention, the method for detecting the concentration of heme solution provided by the present invention will be described in detail below with reference to the examples, but they should not be construed as limiting the protection scope of the present invention.
实施例1Example 1
10μL EDTA(0.1mol/L),10μL青蒿素(5mmol/L),10μL不同浓度血红素标准溶液(0.002,0.005,0.01,0.05,0.1,0.2,0.3,0.5,0.8,2.0,5.0,10.0 μmol/L)及100μL硫胺素(1mmol/L)依次加入到880μL氢氧化钠溶液(0.1 mol/L)中,25℃孵育20分钟后进行荧光光谱测量,利用血红素加入标准溶液前(F0)、后(F)的荧光强度的变化值(ΔF)与血红素的浓度之间的线性关系拟合出标准曲线,见图1~2,图1为加入不同浓度血红素标准溶液后荧光强度的变化;从下到上血红素标准溶液的浓度一次为0,0.002,0.005,0.01,0.05,0.1,0.2,0.3,0.5,0.8,2.0,5.0,10.0μmol/L,图2为体系荧光强度与血红素浓度关系,插图为荧光强度变化和血红素的标准方程,得到的标准方程为ΔF=32.01+23.54c(c为血红素的浓度,单位是nmol/L),线性系数为0.9954,线性范围是2.0~300.0nmol/L,检出限为0.68nmol/L。10μL EDTA (0.1mol/L), 10μL artemisinin (5mmol/L), 10μL heme standard solutions of different concentrations (0.002, 0.005, 0.01, 0.05, 0.1, 0.2, 0.3, 0.5, 0.8, 2.0, 5.0, 10.0 μmol/L) and 100 μL thiamine (1 mmol/L) were sequentially added to 880 μL sodium hydroxide solution (0.1 mol/L), and the fluorescence spectrum was measured after incubation at 25°C for 20 minutes. The linear relationship between the change value (ΔF) of the fluorescence intensity (ΔF) and the heme concentration of 0 ) and after (F) and the concentration of heme was fitted to a standard curve, as shown in Figures 1-2, Figure 1 shows the fluorescence after adding different concentrations of heme standard solutions The change of intensity; the concentration of heme standard solution from bottom to top is 0, 0.002, 0.005, 0.01, 0.05, 0.1, 0.2, 0.3, 0.5, 0.8, 2.0, 5.0, 10.0 μmol/L at one time, Figure 2 shows the fluorescence of the system The relationship between intensity and heme concentration, the inset is the standard equation of fluorescence intensity change and heme, the obtained standard equation is ΔF=32.01+23.54c (c is the concentration of heme, the unit is nmol/L), the linear coefficient is 0.9954, The linear range is 2.0~300.0nmol/L, and the detection limit is 0.68nmol/L.
将待测血红素溶液、乙二胺四乙酸二钠、青蒿素、硫胺素、无机碱与水混合,得到待测混合溶液进行孵育,孵育条件与上述孵育条件相同,得到待测孵育溶液,检测待测孵育溶液的荧光强度,根据标准方程计算得到待测血红素溶液中血红素的浓度,对300nmol/L的血红素溶液进行了6次重复测定,相对标准偏差为6.8%。Mix the heme solution to be tested, disodium EDTA, artemisinin, thiamine, and inorganic base with water to obtain the mixed solution to be tested and incubate, and the incubation conditions are the same as the above incubation conditions to obtain the incubation solution to be tested , detect the fluorescence intensity of the incubation solution to be tested, and calculate the concentration of heme in the heme solution to be tested according to the standard equation. The 300 nmol/L heme solution was repeatedly measured for 6 times, and the relative standard deviation was 6.8%.
实施例2Example 2
与实施例1的步骤相同,区别仅在于将待测血红素溶液替换为含有钴离子、镁离子、铜离子、锌离子和铁离子、葡萄糖、苯丙氨酸、亮氨酸、甘氨酸、丙氨酸和半胱氨酸,对待测血红素溶液进行荧光光谱测定,结果如图3所示,由图3可以看出,发现这些物质加入后体系荧光强度均没有明显变化,只有血红素加入后体系荧光强度明显增强,说明本发明的检测方法表现出较好的选择性,不受一些常见的金属离子及生物分子的干扰。The steps are the same as those in Example 1, except that the heme solution to be tested is replaced with a solution containing cobalt ions, magnesium ions, copper ions, zinc ions and iron ions, glucose, phenylalanine, leucine, glycine, and alanine. Acid and cysteine, the heme solution to be tested was measured by fluorescence spectrum, and the results are shown in Figure 3. It can be seen from Figure 3 that the fluorescence intensity of the system did not change significantly after the addition of these substances, and only the system after the addition of heme The fluorescence intensity is obviously enhanced, indicating that the detection method of the present invention exhibits good selectivity and is not disturbed by some common metal ions and biomolecules.
以上所述仅是本发明的优选实施方式,并非对本发明作任何形式上的限制。应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。The above descriptions are only preferred embodiments of the present invention, and do not limit the present invention in any form. It should be pointed out that for those skilled in the art, without departing from the principle of the present invention, several improvements and modifications can also be made, and these improvements and modifications should also be regarded as the protection scope of the present invention.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810129543.1A CN108318465B (en) | 2018-02-08 | 2018-02-08 | A kind of detection method of heme solution concentration |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810129543.1A CN108318465B (en) | 2018-02-08 | 2018-02-08 | A kind of detection method of heme solution concentration |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108318465A CN108318465A (en) | 2018-07-24 |
CN108318465B true CN108318465B (en) | 2020-12-08 |
Family
ID=62902421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810129543.1A Expired - Fee Related CN108318465B (en) | 2018-02-08 | 2018-02-08 | A kind of detection method of heme solution concentration |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108318465B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111004200A (en) * | 2019-11-11 | 2020-04-14 | 广州中医药大学(广州中医药研究院) | Hydrogenated dichlorofluorescein diacetylamide derivative and preparation method and application thereof |
CN115165828B (en) * | 2022-06-30 | 2025-01-28 | 曲阜师范大学 | A ratio fluorescence analysis method for artemisinin based on Zn-MOF in situ color development |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102370993A (en) * | 2010-08-23 | 2012-03-14 | 王革 | Preparation method for novel red blood cell substitute-artificial red blood cell fluorescent nanoparticles |
JP2012130505A (en) * | 2010-12-21 | 2012-07-12 | Fujifilm Corp | Light measurement system and light measurement method |
CN103293145A (en) * | 2013-05-16 | 2013-09-11 | 赫利森(厦门)生物科技有限公司 | Chemiluminescence reagent |
CN107677658A (en) * | 2017-10-10 | 2018-02-09 | 广西师范学院 | Utilize the method for hemoglobin concentration in nitrogen-doped carbon quantum dots characterization solution |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010009459A1 (en) * | 2008-07-18 | 2010-01-21 | Bayer Healthcare Llc | Methods, devices, and systems for glycated hemoglobin analysis |
-
2018
- 2018-02-08 CN CN201810129543.1A patent/CN108318465B/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102370993A (en) * | 2010-08-23 | 2012-03-14 | 王革 | Preparation method for novel red blood cell substitute-artificial red blood cell fluorescent nanoparticles |
JP2012130505A (en) * | 2010-12-21 | 2012-07-12 | Fujifilm Corp | Light measurement system and light measurement method |
CN103293145A (en) * | 2013-05-16 | 2013-09-11 | 赫利森(厦门)生物科技有限公司 | Chemiluminescence reagent |
CN107677658A (en) * | 2017-10-10 | 2018-02-09 | 广西师范学院 | Utilize the method for hemoglobin concentration in nitrogen-doped carbon quantum dots characterization solution |
Non-Patent Citations (2)
Title |
---|
Artemisinin-luminol chemiluminescence for forensic bloodstain detection using a smart phone as a detector;Wenyue Gao et al.;《Analytical Chemistry》;20170511;第89卷(第11期);第6160~6165页 * |
硫胺素一过氧化氢荧光度法的研究及其应用;揭念琴 等;《分析化学》;19920831;第20卷(第8期);第948页 * |
Also Published As
Publication number | Publication date |
---|---|
CN108318465A (en) | 2018-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hu et al. | Double-strand DNA-templated synthesis of copper nanoclusters as novel fluorescence probe for label-free detection of biothiols | |
CN105441069B (en) | A kind of method using small molecule as the high fluorescence alloy nanocluster of templated synthesis | |
CN104597019A (en) | In-situ composite system based on carbon quantum dot/manganese dioxide nanometer sheet layer and using method for detecting content of glutathione | |
Hua et al. | Size-dependent electrochemiluminescence behavior of water-soluble CdTe quantum dots and selective sensing of l-cysteine | |
CN104865230B (en) | The method of free chlorine in the copper nano-cluster and detection tap water of polyvinylpyrrolidone protection | |
Ma et al. | Fluorescence ratiometric assay for discriminating GSH and Cys based on the composites of UiO-66-NH2 and Cu nanoclusters | |
CN111269715A (en) | Ratiometric fluorescent probe and application thereof in visual detection of glutathione | |
Zhang et al. | Determination of cysteine, homocysteine, cystine, and homocystine in biological fluids by HPLC using fluorosurfactant‐capped gold nanoparticles as postcolumn colorimetric reagents | |
CN108318465B (en) | A kind of detection method of heme solution concentration | |
CN106565721B (en) | A kind of fluorescent reagent and its identification application of selection identification lysine and methionine | |
CN103674919B (en) | A kind of superstructure sensor based on Jenner's popped rice-quantum dot and its preparation method and application | |
CN108690011A (en) | A kind of fluorescence probe of detection cysteine | |
CN108659815A (en) | Golden copper nanocluster fluorescence probe and preparation method thereof for copper ion detection | |
CN108409697A (en) | A kind of highly selective hypochlorous probe of detection of hypersensitive | |
Li et al. | Development of a rapid and simple tetracycline detection system based on metal-enhanced fluorescence by europium-doped AgNP@ SiO 2 core–shell nanoparticles | |
CN108276383A (en) | A kind of fluorescence probe and preparation method thereof of identification iodide ion and recognition methods | |
Wu et al. | A catalyst-free co-reaction system of long-lasting and intensive chemiluminescence applied to the detection of alkaline phosphatase | |
CN104614370A (en) | Quick nitrite detection method based on nanogold | |
CN102507519B (en) | Application of dansyl acid serving as pH fluorescent probe | |
CN103604783B (en) | A kind of method of reversible detection on hypochlorite and sulfuretted hydrogen | |
Hogg et al. | Detection of nitric oxide and peroxynitrite in biological systems: a state-of-the-art review | |
Song et al. | A study of the chemiluminescence behavior of myoglobin with luminol and its analytical applications | |
CN106957891A (en) | The purposes and kit of gold nanoclusters and copper-zinc superoxide dismutase | |
CN105985771B (en) | Detect the method and its kit of ferrous ion | |
Tu et al. | Label-free and highly sensitive electrochemiluminescence biosensing using quantum dots/carbon nanotubes in ionic liquid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20201208 Termination date: 20220208 |
|
CF01 | Termination of patent right due to non-payment of annual fee |